IDT Biologika News

Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.

Twitter
@IDT Biologika

Thursday, 15. July 2021

https://t.co/H93zaMXU8G more info

Tuesday, 29. June 2021

Together with the #GermanRedCross - DRK - we have initiated a #blooddonation campaign on our company premises. 42 e… https://t.co/5xZJEViOtc more info

Friday, 18. June 2021

Wer are very proud to announce that #IDT Biologika was awarded a “Highly Commended” status in the category of “Best… https://t.co/MWMC1WGxza more info

Wednesday, 16. June 2021

We are supporting the planting of 8,000 trees. The campaign was initiated by the Club Soroptimist International Des… https://t.co/ejgqOcVik5 more info

Friday, 11. June 2021

Our story continues. See here the next piece of the exciting 100-year-history of #IDT Biologika. We feature 3… https://t.co/we1HjKzw2E more info

Wednesday, 19. May 2021

We are proud to announce that we are now a member of #VaccinesEurope – a voice for the vaccines industry in Europe.… https://t.co/5RTQ0ZVoh2 more info

Wednesday, 5. May 2021

Running well! Our #IDT running team is taking part in the 10-week running challenge organized by the state of… https://t.co/CMP0jcRGUB more info

Wednesday, 21. April 2021

The next article on our 100 year history is now online. We invite you to learn more about research, #development an… https://t.co/JGo6gV87SS more info

Thursday, 8. April 2021

IDT Biologika has laid the foundation stone for further capacities for the manufacture of active ingredients for va… https://t.co/BhOXDczrNX more info

 

Upcoming Events

CPhI North America

August 10 – 12, 2021
Philadelphia, PA, USA
Pennsylvania Convention Center
more info

13th Bioprocessing Summit

August 16 – 19, 2021
Boston, USA
Sheraton Boston Hotel
more info

Annual Contract Pharma

September 9 – 30, 2021
Virtual
more info

Cell & Gene Meeting on the Mesa

October 12 – 14, 2021 - LIVE
Carlsbad, CA, USA
October 19 – 20, 2021 - VIRTUAL
more info

World Vaccine Congress Europe

October 19-21, 2021
Barcelona
more info

CPhI Worldwide

November 9 – 11, 2021
Milano, Italy
more info

Festival of Biologics

November 9– 11, 2021
Basel, Switzerland
more info

BioProcess International Europe

November 30 – Dezember 2, 2021
Vienna, Austria
more info

World Vaccine & Immunotherapy Congress West Coast

November 30 – Dezember 2, 2021
San Diego, USA
more info

Study with optimized vector vaccine MVA-SARS-2-S resumed

Monday, 19. July 2021

Optimized vector vaccine against corona shows good efficacy in preliminary tests. more info

Federal Minister of Health Jens Spahn and Prime Minister Reiner Haseloff visit IDT Biologika

Monday, 19. April 2021

Dessau-based company to now fill AstraZeneca COVID-19 vaccine - Merz Pharma is foregoing capacities at short notice more info

IDT Biologika lays foundations for new multifunctional vaccine production building

Thursday, 8. April 2021

Overall, a total of 100 million euros are currently being invested in the site... more info

IDT Biologika and Takeda support production of the Johnson & Johnson single-shot COVID-19 vaccine

Monday, 15. March 2021

Takeda provides booked capacity at the IDT site in Dessau more info

Start of second study phase of vector vaccine against COVID-19 postponed

Monday, 11. January 2021

Initial data for corona vaccine indicate good tolerability but weak immune response more info

Corporate Communications

If you are a journalist and have any questions, please don't hesitate to contact us.

Kontaktformular

Corinna Meisel

Corporate Communication

Study with optimized vector vaccine MVA-SARS-2-S resumed

Monday, 19. July 2021 Download

Optimized vector vaccine against corona shows good efficacy in preliminary tests. more info

Federal Minister of Health Jens Spahn and Prime Minister Reiner Haseloff visit IDT Biologika

Monday, 19. April 2021 Download

Dessau-based company to now fill AstraZeneca COVID-19 vaccine - Merz Pharma is foregoing capacities at short notice more info

IDT Biologika lays foundations for new multifunctional vaccine production building

Thursday, 8. April 2021 Download

Overall, a total of 100 million euros are currently being invested in the site... more info

IDT Biologika and Takeda support production of the Johnson & Johnson single-shot COVID-19 vaccine

Monday, 15. March 2021 Download

Takeda provides booked capacity at the IDT site in Dessau more info

Start of second study phase of vector vaccine against COVID-19 postponed

Monday, 11. January 2021 Download

Initial data for corona vaccine indicate good tolerability but weak immune response more info

Federal Minister of Health visits IDT Biologika

Tuesday, 24. November 2020 Download

5 million vaccine doses against COVID-19 more info

IDT Biologika receives official notification of funding from the Federal government

Thursday, 8. October 2020 Download

IDT Biologika receives official notification of funding from the Federal government more info

SARS-CoV-2: IDT Biologika fills vaccine candidate

Wednesday, 29. July 2020 Download

Clinical phase about to begin more info

Deputy leader of the parliamentary FDP visits IDT Biologika

Friday, 10. July 2020 Download

Battle against SARS-CoV-2 at the heart of Germany more info

Positive interim summary of strategic realignment at CPhl trade fair:

Tuesday, 5. November 2019 Download

IDT Biologika expands portfolio of viral vaccines and biologics more info

IDT Biologika Awarded new Task Order to Manufacture Vaccines and Biologics for Infectious Diseases

Monday, 4. November 2019 Download

IDT Biologika Awarded new Task Order in the Scope of 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info

IDT Biologika inaugurates new multifunctional production facility for vaccines at BioPharmaPark area

Friday, 5. July 2019 Download

New building for vaccine production enables even more flexible reaction to customer demands more info

Ceva completes acquisition

Wednesday, 3. July 2019 Download

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split more info

IDT Biologika to concentrate on human vaccines and pharmaceuticals

Wednesday, 5. June 2019 Download

Divestment of animal health business unit enables focus on global growth market more info

Ceva Santé Animale and IDT Biologika GmbH

Friday, 17. May 2019 Download

Ceva Santé Animale and IDT Biologika GmbH announce agreement for Ceva to acquire the IDT animal health business, expanding its global vaccine portfolio and boosting swine innovation more info

CMO Leadership Awards 2019

Tuesday, 26. March 2019 Download

IDT Biologika Receives Six 2019 CMO Leadership Awards more info

IDT Biologika Awarded 10-Year NIH Contract

Friday, 19. October 2018 Download

IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine

Monday, 20. August 2018 Download

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info

25th anniversary of the privatization of IDT Biologika

Friday, 29. June 2018 Download

Prime Minister hails exemplary success story more info

IDT Biologika acquires Dr. Felgenträger, located in the BioPharmaPark Dessau

Tuesday, 24. April 2018 Download

The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info

CMO Leadership Award 2018

Monday, 26. March 2018 Download

IDT Biologika receives three Life Science Leader’s more info

A second managing director for IDT Biologika

Monday, 19. February 2018 Download

Our new senior management team is now complete more info

Official transfer of ownership

Tuesday, 21. November 2017 Download

Former Schade brewery grounds handed off to IDT Biologika more info

Plans to Build Out New, State-of-the-Art Vaccine Manufacturing Hub in Ontario

Monday, 21. August 2017 Download

Plans to Build Out New, State-of-the-Art Vaccine Manufacturing Hub in Ontario more info

30 new laboratories for the vaccines of the future

Monday, 29. May 2017 Download

After two years of construction, IDT Biologika is celebrating the opening of its new research and development building at its Riems site in Greifswald. more info

CMO Leadership Award 2017

Wednesday, 29. March 2017 Download

IDT Biologika receives Life Science Leader’s 2017 CMO Leadership Award in multiple categories more info

IDT Biologika acquires Ridgeway Biologicals Ltd

Thursday, 5. January 2017 Download

UK specialist company for autogenous vaccines to be integrated in IDT’s Global Animal Health Vaccine Network more info

Process Development Laboratory opens in the ZENIT building in Magdeburg, Germany

Wednesday, 2. November 2016 Download

IDT creates new capacities for the development of human vaccines. more info

BARDA Awards IDT Biologika Contract for Live Virus Filling and Finishing Services

Monday, 24. October 2016 Download

BARDA Awards IDT Biologika Contract for Live Virus Filling and Finishing Services more info

CPhI 2016

Thursday, 13. October 2016 Download

IDT Biologika to highlight its role as a reliable partner for extraordinary vaccine and parenteral biologics solutions more info

Strategic collaboration for manufacture of Antibody Drug Conjugates

Wednesday, 12. October 2016 Download

Through their PROVEO Partnership, CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration for Manufacture of Antibody Drug Conjugates more info

One-Year Anniversary in Rockville

Thursday, 15. September 2016 Download

IDT Biologika, a globally integrated manufacturer of vaccines and biopharmaceuticals, announces today the one-year anniversary celebration of its first U.S. contract manufacturing facility in Rockville, Maryland. more info

IDT Biologika sets its sights on broad presence at BIO2016

Tuesday, 7. June 2016 Download

Biologics Manufacturing Leader Will Highlight Continued Worldwide Growth of Operations to Meet Strong Demand for Vaccine and Viral Vector Therapeutics, and Pharmaceutical Development and Production. more info

IDT/Gallant: Expansion of North American Animal Health Operations

Tuesday, 15. March 2016 Download

Collaboration Positions IDT/Gallant as a Leader in Canadian Animal Health Market. Accelerates Development as Canada’s Only “Vaccine-Only” Animal Health Company. more info

Economy Minister Glawe: “A windfall for Mecklenburg- Western Pomerania”

Friday, 4. March 2016 Download

The new building for research and quality control at IDT Riems is moving forward on schedule, with the cornerstone laid last May and the building shell completed at the start of the year. more info

Dessauer high school students support planting initiative

Monday, 15. February 2016

An autonomous and closed site was the goal, when the ground was first broken for the IDT Biologika bypass road in April 2014. more info

CMC Biologics and IDT Biologika Announce a Strategic Collaboration

Thursday, 11. February 2016 Download

CMC Biologics A/S announced the formation of a strategic collaboration to provide a complete and efficient solution for the manufacture of antibody drug conjugates (ADCs). more info

Modern training and conference center planned for Dessau city center

Friday, 22. January 2016 Download

The conference rooms on the second floor of Building 211 were transformed into a press center for the event. more info

IDT Biologika broadens capacities and competencies

Monday, 12. October 2015 Download

Leading-edge vaccine technologies more and more globally recognized. more info

Rockville expands the IDT vaccine development and production offer

Tuesday, 22. September 2015 Download

Plenty has changed in a very short time for IDT Biologika employees in Maryland. On “Day One” they were welcomed to the IDT family and introduced to a company with a significantly different outlook from before. more info

IDT acquires authorized autogenous vaccine manufacturer in Canada

Tuesday, 25. August 2015 Download

Gallant Custom Laboratories in the Canadian city of Cambridge, Ontario has been “an IDT company” since September 1 of this year. more info

IDT with a new location in the U.S.

Tuesday, 23. June 2015 Download

A new partnership has led to a new IDT location. Aeras TB has sold its contract manufacturing division to IDT. more info

Groundbreaking for the new research facility attracts prominent politicians

Tuesday, 26. May 2015 Download

The representatives of government sent a clear signal of support for the site and its development. more info

IDT Biologika receives 2015 FOYA Award from the ISPE

Monday, 20. April 2015 Download

IDT Biologika, a major contract manufacturer of biopharmaceuticals and vaccines, today announced it is the recipient of the 2015 Facility of the Year Award (FOYA) for facility integration. more info

CMO Leadership Award 2015

Wednesday, 18. March 2015 Download

IDT Biologika, a major contract manufacturer of biopharmaceuticals and vaccines, accepted a CMO Leadership Award for quality, reliability, productivity and innovation during a ceremomy held in New York City, March 18th. more info

Hugo Junkers Award 2014

Monday, 15. December 2014 Download

IDT Biologika is sharing the 2014 Hugo Junkers Innovation Award in the Applied Research category with its innovative production process for a recombinant live vaccine. more info

Frost & Sullivan Customer Service Leadership Award

Tuesday, 11. November 2014 Download

Based on its recent analysis of the biopharmaceutical contract manufacturing industry, Frost & Sullivan recognizes IDT Biologika with the 2014 Europe Frost & Sullivan Award for Customer Service Leadership. more info

Joint investment in production capacities at the Dessau site

Download

IDT Biologika and AstraZeneca establish strategic partnership for vaccine production more info